Prolacta Bioscience - About the company
Prolacta Bioscience is a series E company based in Los Angeles (United States), founded in 1999. It operates as a Human milk-based nutrition for vulnerable infants, improving health outcomes. Prolacta Bioscience has raised $98.7M in funding from investors like Draper Richards, Alta Partners and Phillip Capital. The company has 11 active competitors, including 3 funded and 2 that have exited. Its top competitors include companies like BoobyBiome, Lowenzahn Organics and Beingmate Baby Child Food.
Company Details
Human milk-based nutrition for vulnerable infants, improving health outcomes. The company transforms care for preterm and critically ill term infants by unlocking the biological power of human milk. They develop and offer human milk-based products, including fortifiers, to improve health and reduce complications. Their products support feeding tolerance, fuel brain growth, and support adequate growth. They operate pharmaceutical-grade human milk processing facilities, utilizing vat pasteurization and a patented manufacturing process to retain essential bioactive components while ensuring pathogen inactivation. They focus on improving outcomes for babies using human milk nutrition. They are dedicated to quality and safety in human milk processing. They are involved in the life sciences industry, specifically neonatal nutrition. They have a social impact by providing nutrition to vulnerable infants.
- Website
- www.prolacta.com/en/
Key Metrics
Founded Year
1999
Location
Los Angeles, United States
Stage
Series E
Total Funding
$98.7M in 10 rounds
Latest Funding Round
Investors
Ranked
1st among 11 active competitors
Employee Count
322 as on Feb 28, 2026
Similar Companies
Sign up to download Prolacta Bioscience's company profile
Prolacta Bioscience's funding and investors
Prolacta Bioscience has raised a total funding of $98.7M over 10 rounds. Its first funding round was on Jun 23, 2004. Prolacta Bioscience has 16 institutional investors.
Here is the list of recent funding rounds of Prolacta Bioscience:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 14, 2018 | 1527887 | Series E | 2822531 | 4750973 | 8186487 | 2406480 |
May 19, 2017 | 2865079 | Series E | 7982351 | 1391558 | 5877424 | 2662177 |
Dec 06, 2016 | 4197323 | Series E | 5970396 | 1709777 |
View details of Prolacta Bioscience's funding rounds and investors
Prolacta Bioscience's founders and board of directors
Founder? Claim ProfileProlacta Bioscience's employee count trend
Prolacta Bioscience has 322 employees as of Feb 26. Here is Prolacta Bioscience's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Prolacta Bioscience's Competitors and alternates
Top competitors of Prolacta Bioscience include BoobyBiome, Lowenzahn Organics and Beingmate Baby Child Food. Here is the list of Top 10 competitors of Prolacta Bioscience, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Prolacta Bioscience 1999, Los Angeles (United States), Series E | Human milk-based nutrition for vulnerable infants, improving health outcomes | $98.7M | 59/100 | |
2nd | BoobyBiome 2019, London (United Kingdom), Seed | Developer of research-backed microbiome solutions for infant health and well-being | $3.28M | 51/100 | |
3rd | Lowenzahn Organics 2015, Berlin (Germany), Acquired | Provider of food supplements for babies | - | 48/100 | |
4th | Beingmate Baby Child Food 1992, Hangzhou (China), Public | Developer of nutrition products for babies and children | - | 38/100 | |
5th | Pharmacia Laboratorij 2011, Zagreb (Croatia), Unfunded | Provider of baby formula products for infants and toddlers | - | - | 33/100 |
6th | LactaLogics 2014, Port St Lucie (United States), Funding Raised | Provider of human milk-based products for premature and at-risk infants | - | 26/100 | |
7th | 108Labs 2013, United States, Unfunded | Developer of cell-cultured human milk and whole-human infant formula | - | - | 24/100 |
8th | Manzo Pharmaceuticals 2013, Scranton (United States), Unfunded | Lacto-Freedom: Probiotic solution for lactose intolerance, providing lasting dairy relief | - | - | 24/100 |
9th | Healthy Times 1980, San Diego (United States), Deadpooled | Manufacturer & distributor of organic baby food | - | 23/100 | |
10th | BioNascent 2016, San Francisco (United States), Seed | Specialty company developing products for infant health | $250K | 18/100 |
Looking for more details on Prolacta Bioscience's competitors? Click here to see the top ones
Prolacta Bioscience's Investments and acquisitions
Prolacta Bioscience has made no investments or acquisitions yet.
Reports related to Prolacta Bioscience
Here is the latest report on Prolacta Bioscience's sector:
News related to Prolacta Bioscience
Media has covered Prolacta Bioscience for 1 event in last 1 year.
•
Japan Approves Prolacta Bioscience's Human Milk FortifiersPR Newswire•Feb 19, 2026•Prolacta Bioscience
•
•
•
•
David Green Named CFO at Seastar MedicalMedical Product Outsourcing•Mar 21, 2024•Seastar Medical, Prolacta Bioscience
•
•
Prolacta Bioscience to test “precision microbiome engineering” of its synbiotic in stem cell trialsFoodIngredientsFirst•Sep 06, 2023•Prolacta Bioscience
•
•
•
Are you a Founder ?
FAQs about Prolacta Bioscience
Explore our recently published companies
- ReformIQO - Surat based, 2022 founded, Unfunded company
- Glowfarms - Hoorn based, 2020 founded, Public company
- Address Me - Lenasia based, 2004 founded, Seed company
- Kloud Project - Chittagong based, 2020 founded, Funding Raised company
- Pleez - Alcacer Do Sal based, 2020 founded, Funding Raised company
- NOVENER - Nyons based, 2014 founded, Funding Raised company